RELATIONSHIP OF THE TYPE AND POSITION OF MUTATION IN THE FBN1 GENE WITH CLINICAL MANIFESTATIONS OF MARFAN SYNDROME IN CHILDREN

被引:0
作者
Gritsevskaya, D. Yu. [1 ]
Putintsev, A. N. [2 ]
Nikolskiy, D. A. [3 ]
Semyachkina, A. N. [4 ]
Nikolaeva, E. A. [4 ,5 ]
Shkolnikova, M. A. [6 ]
Voinova, V. Yu. [4 ]
机构
[1] Veltischev Res Clin Inst Pediat & Childrens Surg, Clin Genet Dept, Moscow, Russia
[2] Veltischev Res Clin Inst Pediat & Childrens Surg, Informat Technol & Monitoring Dept, Moscow, Russia
[3] Veltischev Res Clin Inst Pediat & Childrens Surg, Moscow, Russia
[4] Veltischev Res Clin Inst Pediat, Clin Genet Dept, Moscow, Russia
[5] Fac Addit Profess Educ, Dept Innovat Pediat & Pediat Surg, Moscow, Russia
[6] Assoc Pediat Cardiologists Russia, Moscow, Russia
来源
YAKUT MEDICAL JOURNAL | 2025年 / 01期
关键词
FBN1; gene; missense mutations; LoF (loss of function) mutations; TGF beta (transforming growth factor beta); children; Marfan syndrome; PATHOGENESIS; ANEURYSM;
D O I
10.25789/YMJ.2025.89.04
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Marfan syndrome (OMIM # 154700) is an inherited connective tissue disease caused by mutations in the FBN1 gene, characterized by marked clinical variability, the causes of which are poorly understood. The aim of this study was to determine the association of the type and localization of the FBN1 gene mutation with the severity of clinical manifestations of Marfan syndrome in a Russian cohort of children. Results: for the first time in a Russian cohort of children, the association between the type and localization of the FBN1 gene mutation and the severity of clinical manifestations was demonstrated: LoF mutations lead to greater damage to the cardiovascular and skeletal systems; missense mutations lead to greater damage to the eyes. Mutations in exons 1-10 lead to the earliest onset of skeletal changes (foot (p=0.016) and chest (p=0.036) deformities), mutations in exons 11-20-to the earliest appearance of lens ectopia (p=0.034), with less severe dolichostenomelia (p=0.041) and less frequent formation of aortic dilatation (p=0.035). Mutations in exons 21-35 are accompanied by the earliest manifestation of spinal deformity (p=0.02). Mutations in exons 51-66 less often lead to lens ectopia (p=0.001).
引用
收藏
页码:16 / 19
页数:4
相关论文
共 10 条
[1]   Clinical relevance of genotype-phenotype correlations beyond vascular events in a cohort study of 1500 Marfan syndrome patients with FBN1 pathogenic variants [J].
Arnaud, Pauline ;
Milleron, Olivier ;
Hanna, Nadine ;
Ropers, Jacques ;
Ould Ouali, Nadia ;
Affoune, Amel ;
Langeois, Maud ;
Eliahou, Ludivine ;
Arnoult, Florence ;
Renard, Philippe ;
Michelon-Jouneaux, Marlene ;
Cotillon, Marie ;
Gouya, Laurent ;
Boileau, Catherine ;
Jondeau, Guillaume .
GENETICS IN MEDICINE, 2021, 23 (07) :1296-1304
[2]   Association of modifiers and other genetic factors explain Marfan syndrome clinical variability [J].
Aubart, Melodie ;
Gazal, Steven ;
Arnaud, Pauline ;
Benarroch, Louise ;
Gross, Marie-Sylvie ;
Buratti, Julien ;
Boland, Anne ;
Meyer, Vincent ;
Zouali, Habib ;
Hanna, Nadine ;
Milleron, Olivier ;
Stheneur, Chantal ;
Bourgeron, Thomas ;
Desguerre, Isabelle ;
Jacob, Marie-Paule ;
Gouya, Laurent ;
Genin, Emmanuelle ;
Deleuze, Jean-Francois ;
Jondeau, Guillaume ;
Boileau, Catherine .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 (12) :1759-1772
[3]   The Molecular Genetics of Marfan Syndrome [J].
Du, Qiu ;
Zhang, Dingding ;
Zhuang, Yue ;
Xia, Qiongrong ;
Wen, Taishen ;
Jia, Haiping .
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (13) :2752-2766
[4]   Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations:: An international study [J].
Faivre, L. ;
Collod-Beroud, G. ;
Loeys, B. L. ;
Child, A. ;
Binquet, C. ;
Gautier, E. ;
Callewaert, B. ;
Arbustini, E. ;
Mayer, K. ;
Arslan-Kirchner, M. ;
Kiotsekoglou, A. ;
Comeglio, P. ;
Marziliano, N. ;
Dietz, H. C. ;
Halliday, D. ;
Beroud, C. ;
Bonithon-Kopp, C. ;
Claustres, M. ;
Muti, C. ;
Plauchu, H. ;
Robinson, P. N. ;
Ades, L. C. ;
Biggin, A. ;
Benetts, B. ;
Brett, M. ;
Holman, K. J. ;
De Backer, J. ;
Coucke, P. ;
Francke, U. ;
De Paepe, A. ;
Jondeau, G. ;
Boileau, C. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 81 (03) :454-466
[5]   Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome [J].
Habashi, JP ;
Judge, DP ;
Holm, TM ;
Cohn, RD ;
Loeys, BL ;
Cooper, TK ;
Myers, L ;
Klein, EC ;
Liu, GS ;
Calvi, C ;
Podowski, M ;
Neptune, ER ;
Halushka, MK ;
Bedja, D ;
Gabrielson, K ;
Rifkin, DB ;
Carta, L ;
Ramirez, F ;
Huso, DL ;
Dietz, HC .
SCIENCE, 2006, 312 (5770) :117-121
[6]   Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome [J].
Judge, DP ;
Biery, NJ ;
Keene, DR ;
Geubtner, J ;
Myers, L ;
Huso, DL ;
Sakai, LY ;
Dietz, HC .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :172-181
[7]   The revised Ghent nosology for the Marfan syndrome [J].
Loeys, Bart L. ;
Dietz, Harry C. ;
Braverman, Alan C. ;
Callewaert, Bert L. ;
De Backer, Julie ;
Devereux, Richard B. ;
Hilhorst-Hofstee, Yvonne ;
Jondeau, Guillaume ;
Faivre, Laurence ;
Milewicz, Dianna M. ;
Pyeritz, Reed E. ;
Sponseller, Paul D. ;
Wordsworth, Paul ;
De Paepe, Anne M. .
JOURNAL OF MEDICAL GENETICS, 2010, 47 (07) :476-485
[8]   Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-l [J].
Pereira, L ;
Lee, SY ;
Gayraud, B ;
Andrikopoulos, K ;
Shapiro, SD ;
Bunton, T ;
Biery, NJ ;
Dietz, HC ;
Sakai, LY ;
Ramirez, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3819-3823
[9]   Etiology and pathogenesis of the Marfan syndrome: current understanding [J].
Pyeritz, Reed E. .
ANNALS OF CARDIOTHORACIC SURGERY, 2017, 6 (06) :595-598
[10]   FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders [J].
Sakai, Lynn Y. ;
Keene, Douglas R. ;
Renard, Marjolijn ;
De Backer, Julie .
GENE, 2016, 591 (01) :279-291